Newton-Cheh Christopher, Cook Nancy R, VanDenburgh Martin, Rimm Eric B, Ridker Paul M, Albert Christine M
MPH, Center for Arrhythmia Prevention, Division of Preventive Medicine, Cardiovascular Division, Brigham and Women's Hospital, 900 Commonwealth Ave E, Boston, MA 02115-1204, USA.
Circulation. 2009 Nov 24;120(21):2062-8. doi: 10.1161/CIRCULATIONAHA.109.879049. Epub 2009 Nov 9.
Although a heritable basis for sudden cardiac death (SCD) is suggested by the impact of family history on SCD risk, common genetic determinants have been difficult to identify. We hypothesized that a common variant at chromosome 9p21 related to myocardial infarction would influence SCD risk.
This was a prospective, nested, case-control analysis among individuals of European ancestry enrolled in 6 prospective cohort studies. Study subjects were followed up for development of SCD, and genotypes for rs10757274 were determined for 492 sudden and/or arrhythmic deaths and 1460 controls matched for age, sex, cohort, history of cardiovascular disease, and follow-up time. Conditional logistic regression with fixed-effects meta-analysis assuming an additive model was used to test for associations. When individual study results were combined in the meta-analysis, each increasing copy of the G allele at rs10757274 conferred a significantly elevated age-adjusted odds ratio for SCD of 1.21 (95% confidence interval, 1.04 to 1.40; P=0.01). Controlling for cardiovascular and lifestyle risk factors strengthened these relationships (odds ratio, 1.29 per G-allele copy; 95% confidence interval, 1.09 to 1.53; P=0.003). These results were not materially altered in sensitivity analyses limited to definite SCD, in models that further controlled for the development of interim cardiovascular disease, or when the highly correlated variant rs2383207 was tested.
The major allele of a single-nucleotide polymorphism previously associated with increased risk of coronary artery disease events is associated with increased risk of SCD in individuals of European ancestry. Study of the mechanism underlying this association may improve our understanding of lethal cardiovascular disease.
尽管家族史对心脏性猝死(SCD)风险有影响提示了SCD存在遗传基础,但常见的遗传决定因素却难以确定。我们推测,与心肌梗死相关的9号染色体p21区域的一个常见变异会影响SCD风险。
这是一项对参与6项前瞻性队列研究的欧洲血统个体进行的前瞻性巢式病例对照分析。对研究对象随访观察SCD的发生情况,并对492例猝死和/或心律失常死亡患者以及1460例年龄、性别、队列、心血管疾病史和随访时间相匹配的对照者测定rs10757274的基因型。采用假定加性模型的固定效应荟萃分析的条件逻辑回归来检验关联性。当在荟萃分析中合并个体研究结果时,rs10757274位点G等位基因每增加一个拷贝,SCD的年龄校正比值比显著升高至1.21(95%置信区间为1.04至1.40;P = 0.01)。控制心血管和生活方式风险因素可强化这些关系(每增加一个G等位基因拷贝,比值比为1.29;95%置信区间为1.09至1.53;P = 0.003)。在仅限于明确SCD的敏感性分析中、在进一步控制中期心血管疾病发生情况的模型中或在检测高度相关变异rs2383207时,这些结果均未发生实质性改变。
先前与冠心病事件风险增加相关的一个单核苷酸多态性的主要等位基因与欧洲血统个体的SCD风险增加相关。对这种关联潜在机制的研究可能会增进我们对致死性心血管疾病的理解。